Clinical trial · Observational
Managing Breast Cancer Treatment: Dyad's Perspectives on Treatment Decision, Financial and Family Burden.
NCT05917444CI-TRIAL-00067490unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to understand the financial burden and treatment decisions, based on both of patient's and family's perspectives in breast cancer patients who receive systemic chemotherapy, targeted therapy or immuno-therapy and their family caregivers .
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (6)
- measure
- Chinese version of the short form 36 health survey questionnaire (SF-36)
- timeFrame
- within the past month
- description
- The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability.
- measure
- FACT-COST(COmprehensive Score for financial Toxicity)
- timeFrame
- Past 7 days
- description
- instrument that assesses the degree of financial distress experienced by cancer patient,12-item COST-PROM the terms used to describe feelings about financial condition have been numerous, including perceived economic well being,personal financial wellness, financial satisfaction, perceived income adequacy, financial stress, debt stress, economic strain, and economic distress.Using the Likert five-point scale, the scores represent the following: 0 indicates 'completely absent,' 1 indicates 'very few,' 2 indicates 'few,' 3 indicates 'some,' and 4 indicates 'very many.' Higher scores indicate better economic conditions
- measure
- M. D. Anderson Symptom Inventory
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * breast cancer 1. Patients with newly diagnosed or recurrent breast cancer who require chemotherapy or targeted immunotherapy as recommended by their physicians 2. Age 20 to 70 3. Within 0.5 to 3 years of newly diagnosed or recurrent breast cancer 4. Ability to perform housework or wage employment before cancer 5. Those whose cognitive function is sufficient to read newspaper news and answer questionnaires * breast cancer family 1. Patient has been 0.5 to 3 years since the first diagnosis or recurrence of breast cancer and the doctor recommends chemotherapy or targeted immunotherapy 2. Patient's self-reported family members who are involved in the patient's physical, social, or medical caregivers with cancer 3. Age 20 to 65 4. Able to perform housework or wage workers 5. Those whose cognitive function is sufficient to read newspaper news and answer questionnaires Exclusion Criteria: * breast cancer 1. Patients who were disabled before suffering from cancer 2. only undergoing surgery or hormone therapy * breast cancer family 1. Persons with physical, mental and social disabilities 2. Family members who are not involved in the patient's physical, social, or medical care for cancer
References
Publications (0)
Data not yet available
No reference posted for this study.